在神经母细胞瘤中放大和代谢重新连接
Marialena Pouliou1, Marianna A Koutsi1, Lydia Champezou1
1Center of Basic Research, Biomedical Research Foundation, Academy of Athens, 4 Soranou Ephessiou St., 11527 Athens, Greece.
Cancers
|October 14, 2023
概括
MYCN放大驱动神经母细胞瘤通过调高与代谢相关的转录因子 (TFs). 这些TF是MYCN的直接目标,揭示了它在瘤代谢中的调节作用.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 癌症涉及基因组和基因表达异常,导致变化的代谢表型.
- 代谢重编程是瘤的标志,包括神经系统中的瘤.
- MYCN放大是神经母细胞瘤中常见的基因组改变,影响瘤进化.
研究的目的:
- 通过计算评估MYCN放大对神经母细胞瘤中与代谢相关的转录因子 (TF) 基因表达的影响.
- 研究MYCN放大和TF过度表达之间的机制性相互关系.
- 确定参与代谢调节的直接MYCN点.
主要方法:
- 综合计算生物学工作流使用已发布的基因组学数据集.
- 基因本体学 (GO) 分析和文献策划以确定与代谢相关的TFs.
- 在MYCN增强和MYCN过度表达系统的ChIP-seq数据集上进行基于Omics的计算生物学评估.
主要成果:
- 在神经母细胞瘤中,MYCN放大显著上调代谢相关的TF编码基因.
- 几个已识别的TF由MYCN直接以强化诱导的方式进行监管.
- MYCN直接准并控制关键代谢调节者的表达.
结论:
- 在神经母细胞瘤的代谢重编程中,MYCN放大起着至关重要的作用.
- MYCN直接调节与代谢相关的TFs网络,有助于瘤表型.
- 了解这种由MYCN驱动的代谢调节,可以了解神经母细胞瘤的发病过程.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K


